MAGI1 and breast cancer: Additionally, we prove that MAGI1 mRNA levels are upregulated after treatment with histone deacetylase (HDAC) inhibitors in different BC cell lines, which suggests that histone deacetylation could be part of the mechanisms that downregulate MAGI1 during tumor progression.